Page 5 - Oriental Fortune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teon Therapeutics Completes $30 Million Series A Financing
News provided by
Share this article
Share this article
SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/  Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, today announced the completion of a $30M Series A financing. The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments, and former Gilead senior executives. All existing investors also participated in the financing round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital. The funds will be used to advance the company s lead A ....

Hong Kong , United Kingdom , Feng Deng , Lina Yao , Dave Chenn , Teon Therapeutics Inc , Cancer Research United Kingdom , Teon Therapeutics , Oceanpine Capital , Oriza Ventures , Lifespan Investments , Northern Light Venture Capital , Kaitai Capital , Oriental Fortune , Chief Executive Officer , Managing Partner , Founding Managing Partner , Northern Light Venture , Silicon Valley , ஹாங் காங் , ஒன்றுபட்டது கிஂக்டம் , ஃபெங் டெங் , லினா யாவ் , புற்றுநோய் ஆராய்ச்சி ஒன்றுபட்டது கிஂக்டம் , ஆயுட்காலம் முதலீடுகள் , வடக்கு ஒளி துணிகர மூலதனம் ,